Stage IIIB Cutaneous Melanoma AJCC v7 Recruiting Phase 1 Trials for Fludarabine (DB01073)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7) | Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01955460 | Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma | Treatment |